Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.44 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | UGT2B7 | P16662 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.40 |
| ▸ | BRD4 | O60885 | 1/20 | 0.39 |
| ▸ | BRD2 | P25440 | 1/20 | 0.39 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.39 |
| ▸ | GBA1 | P04062 | 2/20 | 0.38 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.37 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6055323 | 0.86 | SLC6A2 (0.54) | ALDH1A1TSHRSLC6A2SLC6A4CYP3A4 | |
| SCHEMBL11672124 | 0.85 | MEN1 (0.46) | ALDH1A1TSHRSLC6A2SLC6A4MEN1 | |
| SCHEMBL4734623 | 0.83 | ALDH1A1 (0.50) | ALDH1A1TSHRSLC6A2SLC6A4CYP3A4 | |
| SCHEMBL24687880 | 0.81 | ALDH1A1 (0.48) | ALDH1A1TSHRSLC6A2SLC6A4CYP3A4 | |
| SCHEMBL9334664 | 0.79 | UGT2B7 (0.56) | ALDH1A1CYP3A4MEN1KMT2AUGT2B7 | |
| SCHEMBL9331659 | 0.79 | UGT2B7 (0.56) | ALDH1A1CYP3A4MEN1KMT2AUGT2B7 | |
| SCHEMBL2812852 | 0.79 | UGT2B7 (0.56) | ALDH1A1CYP3A4MEN1KMT2AUGT2B7 | |
| SCHEMBL9331663 | 0.79 | UGT2B7 (0.56) | ALDH1A1CYP3A4MEN1KMT2AUGT2B7 | |
| SCHEMBL6303660 | 0.79 | ALDH1A1 (0.47) | ALDH1A1TSHRSLC6A2SLC6A4CYP3A4 | |
| SCHEMBL24511248 | 0.79 | ALDH1A1 (0.47) | ALDH1A1TSHRSLC6A2SLC6A4CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4458916-A1 | PHOTOCATALYTICALLY ACTIVE COATING COMPOSITION, METHOD FOR THE PRODUCTION THEREOF AND USE THEREOF | TriOptoTec GmbH (DE) | 2024-11-06 | — | — | EP | disclosed |
| US-20220087906-A1 | PHOTOPOLYMERIZATION INITIATOR, PHOTOCURABLE COMPOSITION, CURED PRODUCT, AND DENTAL MATERIAL | MITSUI CHEMICALS, INC. (JP) | 2022-03-24 | — | — | US | disclosed |
| EP-3895681-A1 | PHOTOPOLYMERIZATION INITIATOR, PHOTOCURABLE COMPOSITION, CURED PRODUCT, AND DENTAL MATERIAL | Mitsui Chemicals, Inc. (JP) | 2021-10-20 | — | — | EP | disclosed |
| EP-3357898-B1 | METHOD FOR PRODUCING ORGANIC COMPOUND | FUJIFILM WAKO PURE CHEMICAL CORP (JP) | 2020-11-25 | — | — | EP | disclosed |
| EP-3357898-B1 | METHOD FOR PRODUCING ORGANIC COMPOUND | FUJIFILM WAKO PURE CHEMICAL CORP (JP) | 2020-11-25 | — | — | EP | disclosed |
| US-10351512-B2 | Method of producing organic compound | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2019-07-16 | — | — | US | disclosed |
| US-10351512-B2 | Method of producing organic compound | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2019-07-16 | — | — | US | disclosed |
| US-20180244604-A1 | METHOD OF PRODUCING ORGANIC COMPOUND | FUJIFILM FINECHEMICALS CO., LTD. (JP) | 2018-08-30 | — | — | US | disclosed |
| EP-3357898-A1 | METHOD FOR PRODUCING ORGANIC COMPOUND | Fujifilm Finechemicals Co., Ltd. (JP) | 2018-08-08 | — | — | EP | disclosed |
| EP-3357898-A1 | METHOD FOR PRODUCING ORGANIC COMPOUND | Fujifilm Finechemicals Co., Ltd. (JP) | 2018-08-08 | — | — | EP | disclosed |
| US-20060211717-A1 | Quinoline and quinazoline derivatives and drugs containing the same | KIRIN BEER KABUSHIKI KAISHA (JP) | 2006-09-21 | — | — | US | disclosed |
| EP-1300381-B1 | Process for preparing optically active alcohols | JAPAN SCIENCE & TECH AGENCY (JP) | 2006-03-08 | — | — | EP | disclosed |
| US-6887820-B1 | For producing optically active secondary alcohols, producing optically active compounds useful for various utilities such as intermediates for synthesizing pharmaceutical agents, liquid crystal materials and agents for optical resolution | JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) | 2005-05-03 | — | — | US | disclosed |
| US-6867320-B2 | Substituted phenylalkanoic acid derivatives and use thereof | ASAHI KASEI PHARMA CORPORATION (JP) | 2005-03-15 | — | — | US | disclosed |
| EP-1477472-A1 | SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF | Asahi Kasei Pharma Corporation (JP) | 2004-11-17 | — | — | EP | disclosed |
| US-20040132727-A1 | Quinoline and quinazoline derivatives and drugs containing the same | KIRIN HOLDINGS KABUSHIKI KAISHA (JP) | 2004-07-08 | — | — | US | disclosed |
| EP-1300381-A1 | Process for preparing optically active alcohols | Japan Science and Technology Corporation (JP) | 2003-04-09 | — | — | EP | disclosed |
| EP-1243582-A1 | QUINOLINE AND QUINAZOLINE DERIVATIVES AND DRUGS CONTAINING THE SAME | KIRIN BEER KABUSHIKI KAISHA (JP) | 2002-09-25 | — | — | EP | disclosed |
| US-6184381-B1 | USEFUL AS INTERMEDIATES FOR SYNTHESIZING PHARMACEUTICAL CHEMICALS, LIQUID CRYSTAL MATERIALS AND AGENTS FOR OPTICAL RESOLUTION, REDUCTION, KETONES TO ALCOHOL, IMINES TO AMINES | JAPAN SCIENCE & TECHNOLOGY CORP. (JP) | 2001-02-06 | — | — | US | disclosed |
| EP-0916637-A1 | PROCESS FOR PREPARATING OPTICALLY ACTIVE COMPOUNDS | Japan Science and Technology Corporation (JP) | 1999-05-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180244604-A1 | METHOD OF PRODUCING ORGANIC COMPOUND | LPO, OR10J3, AOX1 | ALDH1A1 790/4885TSHR 4168/4885SLC6A2 2669/4885 |
| US-20060211717-A1 | Quinoline and quinazoline derivatives and drugs containing the same | PDGFRA, PDGFRB, PDGFA | ALDH1A1 2003/4885TSHR 293/4885SLC6A2 1659/4885 |
| US-20220087906-A1 | PHOTOPOLYMERIZATION INITIATOR, PHOTOCURABLE COMPOSITION, CURED PRODUCT, AND DENTAL MATERIAL | PPOX, PRXL2A, RAD51 | ALDH1A1 1491/4885TSHR 4247/4885SLC6A2 4875/4885 |
| US-10351512-B2 | Method of producing organic compound | LPO, OR10J3, AOX1 | ALDH1A1 790/4885TSHR 4168/4885SLC6A2 2669/4885 |
| US-20040132727-A1 | Quinoline and quinazoline derivatives and drugs containing the same | PDGFRA, PDGFRB, PDGFA | ALDH1A1 2059/4885TSHR 394/4885SLC6A2 1868/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.